Acquisition momentum Aptitude Health has actively expanded through acquisitions including Hug Advertising in 2025 and Bamboo Medical in 2023, signaling a growth-focused strategy that broadens capabilities in branding, advertising, and life sciences communications.

AI driven Launch of OncoClinicAI in 2025 introduces an AI-driven patient case-simulation platform, creating opportunities to upsell advanced analytics, data collaboration, and synthetic patient insights for oncology life science clients.

Oncology focus As a leading provider of evidence-based insights and HCP engagement in oncology and hematology, Aptitude Health regularly collaborates with cancer care networks and life sciences teams seeking to influence treatment decisions and patient outcomes.

Strategic partnerships Past and ongoing partnerships with ExceleraRx, OneOncology, and health system networks indicate a strong channel for co-developed programs and education offerings that can be expanded to new oncology ecosystems.

Mid-market scale With a substantial yet mid-sized employee base and revenue in the hundred-million range, Aptitude Health sits in a sweet spot for scalable services to mid-to-large life sciences companies seeking evidence-based insights and HCP engagement.